Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation?

被引:67
作者
Hong, SH
Ondrey, FG
Avis, IM
Chen, Z
Loukinova, E
Cavanaugh, PF
Van Waes, C
Mulshine, JL
机构
[1] NCI, Med Branch, Div Clin Sci, Cell & Canc Biol Dept,Intervent Sect, Bethesda, MD 20892 USA
[2] NIH, Natl Inst Deafness & Other Commun Disorders, Head & Neck Surg Branch, Bethesda, MD 20892 USA
[3] Procter & Gamble Oral Hlth Care Technol Div, Cincinnati, OH USA
关键词
colon cancer; arachidonic acid; inflammatory disease; COX inhibitors;
D O I
10.1096/fj.14.11.1499
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High levels of prostaglandins are produced in human oropharyngeal carcinoma (OPC), Five human OPC cell lines tested expressed both isoforms of cyclooxygenases (COX), The pan-COX inhibitor ketorolac continuously and significantly decreased PGE(2) production and IL-6 and IL-8 levels in all OPC cell lines tested, but did not affect IL-1 alpha, GM-CSF levels, or in vitro tumor cell growth. In contrast, ketorolac reduced OPC growth in vivo. The OPC cell lines used express the IL-6 receptor, and IL-6 stimulation of these cells causes transduction to occur via STAT3 pathway activation. Coincubation with OPC cell lines with conditioned medium from a TPA-exposed HL-60 cells stimulated growth proportional to the IL-6 levels measured in the conditioned medium. This growth effect was specifically inhibited by anti-IL-6 antibody. These results are consistent with cytokine products of inflammatory cells having paracrine growth effects on OPC, If chronic inflammation plays a role in promoting the development of OPC, this mechanism may also apply to other epithelial tumor systems modulated by COX activity.
引用
收藏
页码:1499 / 1507
页数:9
相关论文
共 53 条
[1]   Colon cancer prevention by NSAIDs: What is the mechanism of action? [J].
Ahnen, DJ .
EUROPEAN JOURNAL OF SURGERY, 1998, 164 :111-114
[2]   Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling [J].
Avis, IM ;
Jett, M ;
Boyle, T ;
Vos, MD ;
Moody, T ;
Treston, AM ;
Martinez, A ;
Mulshine, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :806-813
[3]  
Beck J D, 1998, Ann Periodontol, V3, P127, DOI 10.1902/annals.1998.3.1.127
[4]  
Cavanaugh P. F. Jr., 1995, Inflammopharmacology, V3, P313, DOI 10.1007/BF02668026
[5]  
Cavanaugh PF, 1998, J PERIODONTAL RES, V33, P75
[6]  
Chan G, 1999, CANCER RES, V59, P991
[7]   Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis [J].
Chan, TA ;
Morin, PJ ;
Vogelstein, B ;
Kinzler, KW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :681-686
[8]   Metastastic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction [J].
Chen, Z ;
Smith, CW ;
Kiel, D ;
VanWaes, C .
CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (05) :527-537
[9]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[10]   GENOTOXICITY OF TOBACCO-SMOKE AND TOBACCO-SMOKE CONDENSATE [J].
DEMARINI, DM .
MUTATION RESEARCH, 1983, 114 (01) :59-89